Oral misoprostol vs vaginal dinoprostone
Oral misoprostol showed no clear difference in vaginal birth within 24 hours compared with vaginal dinoprostone (low certainty).
- RR 0.93 [0.87, 1]10 studies · 8983 participantsLow
Oral misoprostol showed no clear difference in vaginal birth within 24 hours compared with vaginal dinoprostone (low certainty).
Oral misoprostol probably leads to lower caesarean section compared with vaginal dinoprostone (moderate certainty).
Cervical pull headgear showed no clear difference in lower incisors to mandible at 2 years compared with minor interceptive procedures (control); GRADE not reported.
It is very uncertain whether systemic (oral) betamethasone changes clinical score compared with topical triamcinolone acetonide paste (very low certainty).
Intralesional betamethasone may leads to higher clinical resolution compared with intralesional triamcinolone acetonide (low certainty).
It is very uncertain whether intralesional betamethasone changes clinical score (14 days) compared with intralesional triamcinolone acetonide (very low certainty).
The intervention showed no clear difference in any stroke or operative death (five‐year cumulative) (moderate certainty).
The intervention showed no clear difference in ipsilateral ischaemic stroke, and any operative stroke or death… (moderate certainty).
The intervention showed no clear difference in disabling or fatal ipsilateral ischaemic or operative stroke and… (moderate certainty).
High showed no clear difference in all‐cause mortality – deaths compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).
High showed no clear difference in cardiovascular mortality – cardiovascular deaths compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).
High showed no clear difference in cardiovascular events compared with low alpha‐linolenic acid omega‐3 fats (low certainty).
High showed no clear difference in coronary heart disease mortality – CHD deaths compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).
High showed no clear difference in coronary heart disease events compared with low alpha‐linolenic acid omega‐3 fats (low certainty).
It is very uncertain whether high changes stroke compared with low alpha‐linolenic acid omega‐3 fats (very low certainty).
High probably leads to lower arrhythmias compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).
The review found no eligible studies for this question.
It is very uncertain whether high changes harms: pulmonary embolus or DVT compared with low alpha‐linolenic acid omega‐3 fats (very low certainty).
The review found no eligible studies for this question.